Z. Slobodnjak (Zagreb, Croatia), E. Quoix (Strasbourg, France)
Pneumocystis carinii pneumonia complicating thoracic external radiotherapy for lung cancer
L. Bigay-Game, X. Game, S. Pontier, I. Latorzeff, C. Hermant, J. M. Bachaud (Toulouse, France)
|  |
Treatment of chemotherapy induced febrile neutropenia in patients with lung and pleural tumours with ertapenem
A. Kuhnke, M. Serke, R. Erbes, H. Lode (Berlin, Germany)
| |
The prevalance of tuberculosis in patients with lung cancer
A. Atasever, T. Goksel, D. Yazan Atasever, T. Aysan (Izmir, Turkey)
| |
Second primary lung cancer
D. S. Tofolean, L. I. Grigorov, F. S. Voinea (Constantza, Romania)
| |
Risk of venous thromboembolism in lung cancer
A. L. Evans, S. J. Linnane (Penarth, United Kingdom)
| |
Alteration in clotting system in non-small cell lung cancer patients
D. Dworakowska, M. Lapinski, A. Skibowska, A. Mital, D. Tomaszewski, R. Dworakowski, E. Kazimierska, J. Skokowski, A. Szutowicz, E. Czestochowska (Gdansk, Poland)
| |
Brain metastasis in lung cancer – our 5-year experience
J. Moldvay, A. Szita, A. Nyizsnyanszki, J. Strausz (Torokbalint, Hungary)
| |
Role of radiotherapy in the tretment of superior vena cava syndrome caused by lung cancer
S. S. Vucicevic, N. P. Jovanovic-Korda, G. A. Gligorijevic (Belgrade, Serbia & Montenegro)
| |
Can shuttle walk predict surgical outcome in lung cancer surgery?
T. Win, A. Jackson, A. Ritchie, F. Wells, C. Laroche (Cambridge, United Kingdom)
| |
Comparisson of lung function tests parameters and dyspnoea score by EORTC quality of life questionnaire C30 in patients with non-small cell lung cancer
S. Rancic, M. Rancic, J. Dukic, D. Djordjevic, I. Stankovic, L. Ristic, T. Pejcic (Nis, Serbia)
| |
ECG changes after lobectomy for (due to) lung carcinoma
N. R. Vasic, M. D. Ercegovac, R. S. Stevic, V. R. Djukanovic, D. D. Trifunovic (Belgrade, Serbia & Montenegro)
| |
Comparison of quality of life in patients with non-small cell lung cancer treated by chemotherapy or radiotherapy
M. Rancic, S. Rancic, M. Cekic, M. Radovic, T. Pejcic, I. Stankovic, L. Ristic, D. Zivkovic (Nis, Serbia)
| |
The effect of lung cancer surgery on quality of life
T. Win, C. M. Laroche, F. C. Wells, A. J. Ritchie (Cambridge, United Kingdom)
| |
Quality of life analysis in patients with NSCLC before and after chemotherapy
J. Talalaj, A. D. Matejczuk, E. Chyczewska, W. Naumnik, T. Izycki (Bialystok, Poland)
| |
Open and close thoracotomy rate: can the physician contribute?
T. Win, A. Tasker, F. Wells, A. Ritchie, S. Wilkinson, C. M. Laroche (Cambridge, United Kingdom)
| |
Performance status as predictor factor of quality of life in patients with non-small cell lung cancer
M. Rancic, S. Rancic, M. Cekic, M. Radovic, T. Pejcic, L. Ristic, I. Stankovic (Nis, Serbia)
| |
Prognostic factors affecting survival in advanced non-small cell lung cancer patients
N. Songur, U. Ok, M. Dinc, C. Ozdilekcan (Ankara, Turkey)
| |
Is Cyfra 21-1 serum level predictive for the type of response to treatment or survival in locally advanced and metastatic non-small cell lung cancer (NSCLC)?
M. Szturmowicz, M. Zaleska, J. Zych, B. Roszkowska, R. Langfort, U. Demkow, K. Roszkowski-Sliz (Warsaw, Poland)
| |
Causes of death in inoperable non small cell lung cancer (NSCLC)-retrospective study
T. Gregoratou, P. Michalopoulou, E. Chondrou, C. Papageorgiou, I. Beltegris, D. Chaimala, A. Klitsa, F. Dariotaki, G. Blazoyiannakis, D. Antoniou (Athens, Greece)
| |
Serum neuron-specific enolase - a marker for disease extent and response to therapy of small-cell lung cancer
M. Petrovic, N. Ilic, I. Jevtovic, S. Mojsilovic (Kragujevac, Belgrade, Serbia)
| |